Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Zheng, Meijuan, Gao, Yong, Wang, Gang, Song, Guobin, Liu, Siyu, Sun, Dandan, Xu, Yuanhong, Tian, Zhigang·2020·Cellular & Molecular Immunology
DOI 10.1038/s41423-020-0402-2

Cited by (1,000)

Items 401–500 of 1,000

  1. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
    Manish K. Dhawan, Ali Ahmed Rabaan, Mahmoud M. Fawarah, Souad A. Almuthree, Roua Abdullah Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi et al. · 2023 · Vaccines
  2. Dysregulation of the immune response affects the outcome of critical COVID‐19 patients
    Linlin Wei, Wenjing Wang, Dexi Chen, Bin Xu · 2020 · Journal of Medical Virology
  3. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
    Kawaljit Kaur, Meng-Wei Ko, Nick Ohanian, Jessica Cook, Anahid Jewett · 2020 · Scientific Reports
  4. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
    Aziz Rodan Sarohan, Murat Kızıl, Ahmet Çağkan İnkaya, Shokhan Osman Mahmud, Muhammad Akram, Osman Çen · 2021 · Cellular Signalling
  5. Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
    Moazzam Shahzad, Sibgha Gull Chaudhary, Muhammad Usman Zafar, Maha Awaiz Hassan, Ali Hussain, Fatima Ali, Iqra Anwar, Mamoon Ahmed, Nausheen Ahmed, Sharad Khurana et al. · 2022 · Transplant Infectious Disease
  6. Understanding the role of vitamin A and its precursors in the immune system
    Murat Gürbüz, Şule Aktaç · 2022 · Nutrition Clinique et Métabolisme
  7. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain
    Sergi Cantenys-Molina, Eduardo Fernández‐Cruz, P Francos, J. C. Lopez Bernaldo de Quiros, Patricia Muñóz, Juana Gil-Herrera · 2020 · Clinical & Experimental Immunology
  8. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure
    Alessandra Stasi, Giuseppe Castellano, Elena Ranieri, Barbara Infante, Giovanni Stallone, Loreto Gesualdo, Giuseppe Stefano Netti · 2020 · Journal of Clinical Medicine
  9. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
    Lauren M. Meyers, Andrés H. Gutiérrez, Christine Boyle, Frances E. Terry, Bethany McGonnigal, Andres Μ. Salazar, Michael F. Princiotta, Wiliam D. Martin, Anne Searls De Groot, Leonard Moise · 2021 · npj Vaccines
  10. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
    Stéphanie Bibert, Nicolas Guex, João Lourenço, Thomas Brahier, Matthaios Papadimitriou‐Olivgeris, Lauro Damonti, Oriol Manuel, Robin Liechti, Lou Götz, Jonathan Tschopp et al. · 2021 · Frontiers in Immunology
  11. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
    Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris · 2022 · PeerJ
  12. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
    Montserrat Torres, Guiomar Casado‐Fernández, Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Fernando Ramos-Martín, Daniel L. Wolf, José Sanz, Pablo Ryan, María Luisa Taboada Martínez et al. · 2022 · Biomedicine & Pharmacotherapy
  13. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
    Taif Shah, Zahir Shah, Nafeesa Yasmeen, Zulqarnain Baloch, Xueshan Xia · 2022 · Frontiers in Immunology
  14. Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19
    Ahmed Saati, Faisal Al-Husayni, Afnan A Malibari, Anas A Bogari, Maher Alharbi · 2020 · Cureus
  15. A Narrative Review of COVID-19: The New Pandemic Disease.
    Kiana Shirani, Erfan Sheikhbahaei, Zahra Torkpour, Mazyar Ghadiri Nejad, Bahareh Kamyab Moghadas, Matina Ghasemi, Hossein Akbari Aghdam, Athena Ehsani, Saeed Saber‐Samandari, Amirsalar Khandan · 2020 · PubMed Central
  16. The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19
    Maksim V. Baranov, Frans Bianchi, Geert van den Bogaart · 2020 · Cells
  17. The role of natural killer cells in liver inflammation
    Andrew J. Highton, Iona S. Schuster, Mariapia A. Degli‐Esposti, Marcus A. Altfeld · 2021 · Seminars in Immunopathology
  18. Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
    Lara Herrera, Myriam Martin‐Inaraja, Silvia J. Santos, Marta Inglés‐Ferrándiz, Aida Azkarate, Miguel Ángel Pérez-Vaquero, Miguel Ángel Vesga, Jose L. Vicario, Bernat Soria, Carlos Solano et al. · 2021 · Immunology
  19. SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
    Madeline J. Lee, Michelle Leong, Arjun Rustagi, Aimee Beck, Leiping Zeng, Susan Holmes, Lei S. Qi, Catherine A. Blish · 2022 · Cell Reports
  20. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
    Joseph Yunis, Kirsty Renfree Short, Di Yu · 2023 · Trends in Microbiology
  21. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
    the RICO study group, Fabienne Venet, Martin Cour, Thomas R. Rimmele, Sébastien Viel, Hodane Yonis, Rémy Coudereau, Camille Amaz, Paul Abraham, Céline Monard et al. · 2021 · Critical Care
  22. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019
    Enrique Bernal, Lourdes Gimeno, María J Alcaraz, Ahmed Abdul Quadeer, Marta Moreno, María V. Martínez‐Sánchez, Jose Antonio Campillo, Jose M Gomez, Ana Peláez, Elisa García et al. · 2021 · The Journal of Infectious Diseases
  23. Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression
    Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan · 2021 · Reviews in Medical Virology
  24. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
    Min-Tser Liao, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, Mei‐Chen Lee, Wan‐Chung Hu, Kuo‐Wang Tsai, Chung‐Hsiang Yang, Chien‐Lin Lu, Sheng-Kang Chiu, Kuo‐Cheng Lu · 2021 · Antioxidants
  25. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19
    Topu Raihan, Muhammad Fazle Rabbee, Puja Roy, Swapnila Choudhury, Kwang-Hyun Baek, Abul Kalam Azad · 2021 · Frontiers in Molecular Biosciences
  26. Dengue and COVID-19: two sides of the same coin
    Gathsaurie Neelika Malavige, Chandima Jeewandara, Graham Stuart Ogg · 2022 · Journal of Biomedical Science
  27. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
    Z. Khoshkam, Y. Aftabi, P. Stenvinkel, B. P. Lawrence, M. Rezaei, G. Ichihara, S. Fereidouni · 2021 · Journal of Advanced Research
  28. Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
    Weihang He, Xiaoqiang Liu, Bing Hu, Dongshui Li, Luyao Chen, Yu Li, Yechao Tu, Situ Xiong, Gongxian Wang, Jun Deng et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  29. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors
    Jarin Taslem Mourosi, Saeed Anwar, Mohammad Jakir Hosen · 2022 · Infection Genetics and Evolution
  30. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis
    Adonis Sfera, Carolina Osorio, Nyla Jafri, Eddie Lee Diaz, Jose E. Campo Maldonado · 2020 · Frontiers in Immunology
  31. Deciphering SARS-CoV-2 Virologic and Immunologic Features
    Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, Loïc Raffray, Philippe Gasque · 2020 · International Journal of Molecular Sciences
  32. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
    Evgeny Lvovich Nasonov, Tatiana Valentinovna Beketova, Tatiana Magomedalievna Reshetnyak, Aleksander M. Lila, L. Ananieva, Tatyana Andreyevna Lisitsyna, S. K. Soloviev · 2020 · Rheumatology Science and Practice
  33. Herpes zoster ophthalmicus in COVID‐19 patients
    Ahmad Nofal, Mohamed M. Fawzy, Sherif Mohammed Sharaf El Deen, Esraa E. El‐Hawary · 2020 · International Journal of Dermatology
  34. Immune system changes during COVID-19 recovery play key role in determining disease severity
    Farshid Fathi, Ramin Sami, Samaneh Mozafarpoor, Hossein Hafezi, Hossein Motedayyen, Reza Arefnezhad, Nahid Eskandari · 2020 · International Journal of Immunopathology and Pharmacology
  35. Review of registered clinical trials for the treatment of COVID‐19
    Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri‐Asl, Hossein Hosseinzadeh · 2020 · Drug Development Research
  36. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19
    Loukman Omarjee, Frédérique Perrot, Olivier Meilhac, Guillaume Mahé, Guilhem Bousquet, Anne Janin · 2020 · Aging
  37. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic
    Negin Kazemian, Dina H. Kao, Sepideh Pakpour · 2021 · International Journal of Molecular Sciences
  38. Diagnosis and Prognosis of COVID-19 Disease Using Routine Blood Values and LogNNet Neural Network
    Mehmet Tahir Huyut, Andrei Velichko · 2022 · Sensors
  39. Harnessing Memory NK Cell to Protect Against COVID-19
    Saeede Soleimanian, Ramin Yaghobi · 2020 · Frontiers in Pharmacology
  40. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
    Vijay Kumar · 2020 · International Immunopharmacology
  41. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets
    Sanja D. Matic, Suzana Popović, Predrag M. Djurdjevic, Danijela Todorović, Nataša Djordjević, Željko Mijailović, Predrag S. Sazdanovic, Dragan R Milovanovic, Dejana Ružić Zečević, Marina D. Petrovic et al. · 2020 · PLoS ONE
  42. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
    Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit · 2022 · PLoS Pathogens
  43. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis
    Michele Gringeri, Vera Battini, Gianluca Cammarata, Giulia Mosini, Greta Guarnieri, Chiara Leoni, Marco Pozzi, Sonia Radice, Emilio Clementi, Carla Carnovale · 2022 · Expert Review of Vaccines
  44. An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
    Erin E. Gaughan, Tom Michael Quinn, Andrew Mills, Annya M. Bruce, Jean Antonelli, Alison C. MacKinnon, Vassilios Aslanis, Feng Li, Richard A. O’Connor, Cecilia Boz et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
  45. Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
    Igor Vladimirovich Kudryavtsev, Natalia A. Arsentieva, Zoia R. Korobova, Dmitry Isakov, Artem Rubinstein, Oleg K. Batsunov, I. V. Khamitova, Raisa N. Kuznetsova, Савин Тихон Валерьевич, Tatiana Akisheva et al. · 2022 · Viruses
  46. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.
    Federico Pasin, Matteo Mascalchi Calveri, Alberto Calabrese, Ginevra Pizzarelli, Isabel Bongiovanni, Michele Andreoli, Chiara Cattaneo, Giovanni Rignanese · 2020 · PubMed Central
  47. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China
    Xing Chen, Jide Huang, Ying Huang, Jiabin Chen, Yingyi Huang, Xiaowen Jiang, Yaling Shi · 2020 · Human Immunology
  48. An overview of COVID‐19 in people with diabetes: Pathophysiology and considerations in the inpatient setting
    Nicola Fleming, Lori J. Sacks, Cecilia T. Pham, Sandra L. Neoh, Elif Ilhan Ekinci · 2020 · Diabetic Medicine
  49. Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study
    Yi Jiang, Subi Abudurexiti, Meng-Meng An, Da Cao, Jie Wei, Ping Gong · 2020 · Scientific Reports
  50. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome
    Pelagia Cuvelier, Hélène Roux, Anne Couëdel-Courteille, Jacques Dutrieux, Cécile Naudin, Bénédicte Charmeteau-De Muylder, Rémi Cheynier, Pierre Squara, Stéfano Marullo · 2021 · Critical Care
  51. Predictive Value of Prognostic Nutritional Index on COVID-19 Severity
    Zhonghua Wang, Yingwen Lin, Xuebiao Wei, Fei Li, Xiaolong Liao, Huiqing Yuan, Daozheng Huang, Tiehe Qin, Heng Geng, Shou-Hong Wang · 2021 · Frontiers in Nutrition
  52. Immune memory in convalescent patients with asymptomatic or mild COVID-19
    Quanxin Long, Yanjun Jia, Xin Wang, Haijun Deng, Xiaoxia Cao, Jun Yuan, Liang Fang, Xu-Rong Cheng, Chao Luo, An-Ran He et al. · 2021 · Cell Discovery
  53. Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity
    Myung‐Ho Kim, Shadi Salloum, Jeffrey Y. Wang, Lai Ping Wong, James Regan, Kristina Lefteri, Zachary Manickas-Hill, Ce Gao, Jonathan Z. Li, Ruslan I. Sadreyev et al. · 2021 · The Journal of Infectious Diseases
  54. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
    Béhazine Combadière, Lucille Adam, Noëlline Guillou, Paul Quentric, Pierre Rosenbaum, Karim Dorgham, Olivia Bonduelle, Christophe Parizot, Delphine Sauce, Julien Mayaux et al. · 2021 · Frontiers in Immunology
  55. Immunotherapy for SARS-CoV-2: potential opportunities
    Mehrnoosh Pashaei, Nima Rezaei · 2020 · Expert Opinion on Biological Therapy
  56. Vitamin D and Covid‐19: From potential therapeutic effects to unanswered questions
    Majid Teymoori‐Rad, Sayed Mahdi Marashi · 2020 · Reviews in Medical Virology
  57. On the genetics and immunopathogenesis of COVID-19
    Chaim O. Jacob · 2020 · Clinical Immunology
  58. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review
    Salleh N. Ehaideb, Mashan L. Abdullah, Bisher Abuyassin, Abderrezak Bouchama · 2020 · Critical Care
  59. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
    Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, Jinguo Ye, Wen Wen, Hao Tang, Wenru Su et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  60. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
    Lorena Vigón, Daniel Fuertes, Javier García‐Pérez, Montserrat Torres, Sara Rodríguez-Mora, Elena Mateos, Magdalena Corona, Adolfo Sáez, Rosa Malo de Molina, Cristina Navarro et al. · 2021 · Frontiers in Immunology
  61. The role of estradiol in the immune response against COVID-19
    Adrián Ramírez-de-Arellano, Jorge Gutiérrez‐Franco, Erick Sierra Díaz, Ana Laura Pereira-Suárez · 2021 · HORMONES
  62. Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
    Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi · 2023 · Future Virology
  63. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
    Sara Cacciapuoti, Annunziata De Rosa, Monica Gelzo, Matteo Megna, Maddalena Raia, Biagio Pinchera, Agostina Pontarelli, Riccardo Scotto, Emanuele Scala, Francesco Scarano et al. · 2020 · Life Sciences
  64. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity
    Teng Liu, Peilin Jia, Bingliang Fang, Zhongming Zhao · 2020 · Frontiers in Microbiology
  65. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients
    Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, Peter Kenneth Smith, Olivia J. Ly Lesslar, Gary Deed, Sonya Marshall‐Gradisnik · 2022 · Molecular Medicine
  66. The Weight of Obesity in Immunity from Influenza to COVID-19
    Fernanda Brandi Andrade, Ana Cristina Moura Gualberto, CAMILA PEREIRA DE REZENDE, Nathércia Percegoni, Jacy Gameiro, Eugênio Damaceno Hottz · 2021 · Frontiers in Cellular and Infection Microbiology
  67. COVID-19 Immunobiology: Lessons Learned, New Questions Arise
    Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas · 2021 · Frontiers in Immunology
  68. Natural killer cells in sepsis: Friends or foes?
    Fangjie Wang, Yiqin Cui, Dongmei He, Lisha Gong, Huaping Liang · 2023 · Frontiers in Immunology
  69. Oral hygiene risk factor
    Victoria Sampson · 2020 · BDJ
  70. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects
    Bogdan Doroftei, Ovidiu‐Dumitru Ilie, Roxana-Oana Cojocariu, Alin Stelian Ciobica, Radu Maftei, Delia Grab, Emil Anton, Jack McKenna, Nitasha Dhunna, Gabriela Simionescu · 2020 · Molecules
  71. Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report
    Khalil Fattouch, Salvatore Corrao, Ettore Augugliaro, Alberto Minacapelli, Angela Nogara, Giulia Zambelli, Christiano Argano, Marco Moscarelli · 2020 · Journal of Thoracic and Cardiovascular Surgery
  72. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
    Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning · 2021 · Frontiers in Immunology
  73. Multi-facets of neutrophil extracellular trap in infectious diseases: Moving beyond immunity
    Zahra Azimzadeh Tabrizi, Arezou Khosrojerdi, Saeed Aslani, Maryam Hemmatzadeh, Farhad Babaie, Amir Bairami, Navid Shomali, Ramin Hosseinzadeh, Roghaiyeh Safari, Hamed Mohammadi · 2021 · Microbial Pathogenesis
  74. Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
    Ilias Christodoulou, Ruyan Rahnama, Jonas W. Ravich, Jaesung Seo, Sergey N. Zolov, Andrew Marple, David M. Markovitz, Challice Lee Bonifant · 2021 · Frontiers in Immunology
  75. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
    Sara Chiappalupi, Laura Salvadori, Aleksandra Vukašinović, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi · 2021 · Life Sciences
  76. Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection
    Yingying Zhang, Yuan Gan, Jia Wang, Zhixin Feng, Zhaoxin Zhong, Hongduo Bao, Qiyan Xiong, Ran Wang · 2022 · mSystems
  77. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
    Roshini Sarah Abraham, Joanna M. Marshall, Hye Sun Kuehn, Cesar Mauricio Rueda, Amber Gibbs, Will Guider, Claire A. Stewart, Sergio D. Rosenzweig, Huanyu Wang, Sophonie Jean et al. · 2020 · Journal of Allergy and Clinical Immunology
  78. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19
    Baolin Liao, Zhi-Peng Liu, Li-Bo Tang, Linghua Li, Qingxin Gan, Haiyan Shi, Qian Jiao, Yujuan Guan, Min Xie, Xi He et al. · 2020 · International Journal of Medical Sciences
  79. Pre-test probability for SARS-Cov-2-related infection score: The PARIS score
    Mickaël Tordjman, Ahmed Mekki, Rahul D. Mali, Inès Saab, Guillaume Chassagnon, Enora Guillo, Robert T Burns, Déborah Eshagh, Sébastien Beaune, Guillaume Madelin et al. · 2020 · PLoS ONE
  80. Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital
    Anahita Mostaghim, Pranay Sinha, Catherine G. Bielick, Selby Knudsen, Indeevar R. Beeram, Laura Forsberg White, Caroline Margaret Apovian, Manish Sagar, Natasha S. Hochberg · 2020 · PLoS ONE
  81. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status
    Yonggang Zhou, Jinhe Zhang, Dongyao Wang, Dong Wang, Wuxiang Guan, Jingkun Qin, Xiuxiu Xu, Jingwen Fang, Binqing Fu, Xiaohu Zheng et al. · 2021 · Journal of Autoimmunity
  82. Identification of PBMC-based molecular signature associational with COVID-19 disease severity
    Hibah Shaath, Nehad M. Alajez · 2021 · Heliyon
  83. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls
    Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M. Yapanto, Mohsen Nabi‐Afjadi, Mohsen Aksoun, Maryam Nasr Esfahani, Fatemeh Aghakhani, Mahsa Movahed et al. · 2021 · International Immunopharmacology
  84. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
    Yasutomi Higashikuni, Wenhao Liu, Takumi Obana, Masataka Sata · 2021 · International Journal of Molecular Sciences
  85. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
    Claudio Fenizia, Silvia Galbiati, Claudia Vanetti, Riccardo Vago, Mario Clerici, Carlo Tacchetti, Tiziana Daniele · 2022 · Microbiology Spectrum
  86. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
    Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, Óscar Cabrera-Marante, Daniel Arroyo‐Sánchez, Esther Mancebo, Daniel Enrique Pleguezuelo, Edgard Alfonso Rodriguez-Frias, Luis Miguel Allende, Pablo Morales-Pérez et al. · 2022 · Biomedicines
  87. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interface
    Juliette Léon, Daniel A. Michelson, Judith Olejnik, Kaitavjeet Chowdhary, Hyung Suk Oh, Adam J. Hume, Silvia Galván-Peña, Yangyang Zhu, Felicia Chen, Brinda Vijaykumar et al. · 2021 · Proceedings of the National Academy of Sciences
  88. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein
    Lavanya Visvabharathy, Barbara Ann Hanson, Zachary S. Orban, Patrick H. Lim, Nicole M. Palacio, Millenia Jimenez, Jeffrey R. Clark, Edith L. Graham, Eric Michael Liotta, George Tachas et al. · 2023 · Frontiers in Immunology
  89. COVID-19: the new challenge for rheumatologists. First update
    Francesco Ferro, Elena Elefante, Ilaria Puxeddu, Chiara Baldini, Elena Bartoloni, Claudia Baratè, Sara Galimberti, Rosaria Talarico, Marta Mosca, Stefano Bombardieri · 2020 · Clinical and Experimental Rheumatology
  90. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
    Claudia Matteucci, Antonella Minutolo, Emanuela Balestrieri, Vita Petrone, Marialaura Fanelli, Vincenzo Malagnino, Marco Ianetta, Alessandro Giovinazzo, Filippo Barreca, Silvia Di Cesare et al. · 2020 · Open Forum Infectious Diseases
  91. COVID and Lung Cancer
    Luana Calabrò, Giulia Rossi, Alessia Covre, Aldo Morra, Michele Maio · 2021 · Current Oncology Reports
  92. Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
    Lin Li, Yuzheng C. Wu, Jiabao Wang, Huimin Yan, Jia Lu, Yu Wang, Boli Zhang, Junhua Zhang, Jian Yang, Xiaoying Wang et al. · 2021 · Engineering
  93. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
    Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
  94. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control
    Sreus A. G. Naidu, Roger Clemens, A. Satyanarayan Naidu · 2022 · Journal of Dietary Supplements
  95. Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
    Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, Santosha Adipudi Vardhana, Caroline Robert, Ramy A. Ibrahim, Andrea Anichini et al. · 2020 · Clinical Cancer Research
  96. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
    Jun Wu, Xiaohui Yuan, Bing Wang, Rui Gu, Wei Li, Xuemei Xiang, Lijun Tang, Hongyu Sun · 2020 · Frontiers in Microbiology
  97. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
    Pengjiao An, Yi Zhun Zhu, Li-ping Yang · 2020 · Pharmacological Research
  98. Regulatory CD4+ and CD8+ T cells are negatively correlated with CD4+/CD8+ T cell ratios in patients acutely infected with SARS-CoV-2
    Menglu Gao, Yili Liu, Mingquan Guo, Qianying Wang, Yan Wang, Jian‐Gao Fan, Yinzhong Shen, Junjie Hou, Yanmin Wan, Zhaoqin Zhu · 2020 · Journal of Leukocyte Biology
  99. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Faria N. Ahmed, Donghyeon Jo, Seung‐Hwan Lee · 2020 · Frontiers in Immunology
  100. Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
    Rachel S. Cooper, Alasdair R. Fraser, Linda M. Smith, Paul Burgoyne, Stuart N. Imlach, LISA M. JARVIS, David M. Turner, Sharon Zahra, Marc L. Turner, John D. Campbell · 2021 · Frontiers in Immunology